SCHEMBL4935609

SCHEMBL4935609

Cc1cc(CC(=O)O)ccc1-c1ccc(O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 2/20 0.57
SOAT1 P35610 2/20 0.57
CA2 P00918 1/20 0.56
CAMK2A Q9UQM7 1/20 0.56
RXRA P19793 3/20 0.52
RXRB P28702 3/20 0.52
RXRG P48443 2/20 0.52
HSD17B1 P14061 1/20 0.51
ESR2 Q92731 1/20 0.50
PSEN1 P49768 1/20 0.50
PSEN2 P49810 1/20 0.50
APH1B Q8WW43 1/20 0.50
NCSTN Q92542 1/20 0.50
APH1A Q96BI3 1/20 0.50
PSENEN Q9NZ42 1/20 0.50
AKR1B1 P15121 2/20 0.49
HSD17B10 Q99714 2/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 2/20 0.47
TSHR P16473 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4943262 0.90 HSD17B1 (0.59) DGAT1SOAT1CA2CAMK2ARXRA
SCHEMBL5822623 0.87 DGAT1 (0.56) DGAT1SOAT1RXRARXRBRXRG
SCHEMBL4943034 0.83 CA2 (0.55) CA2CAMK2ARXRARXRBRXRG
SCHEMBL4942093 0.81 CA2 (0.53) CA2CAMK2ARXRARXRBHSD17B1
SCHEMBL10458145 0.81 ESR2 (0.53) CA2HSD17B1ESR2HSD17B10HCAR2
SCHEMBL4943055 0.81 CA2 (0.56) DGAT1SOAT1CA2CAMK2APSEN1
SCHEMBL4937928 0.81 CA2 (0.60) DGAT1SOAT1CA2CAMK2AHSD17B1
SCHEMBL4943785 0.80 CA2 (0.51) DGAT1SOAT1CA2CAMK2ARXRA
Methane SCHEMBL11691361 0.79 CA2 (0.55) DGAT1SOAT1CA2CAMK2APSEN1
SCHEMBL11702184 0.79 RXRA (0.55) DGAT1SOAT1RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255111-A1 Tissue Factor Production Inhibitor PTAFR, PLAT, TFPI DGAT1 120/4885SOAT1 535/4885CA2 4718/4885
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 DGAT1 2743/4885SOAT1 589/4885CA2 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.